Skip to Content

T. Rowe Price Health Sciences PRHSX

Analyst rating as of
NAV / 1-Day Return
109.53  /  0.08 %
Total Assets
19.3 Bil
Adj. Expense Ratio
0.760%
Expense Ratio
0.760%
Fee Level
Low
Longest Manager Tenure
5.54 years
Category
Health
Investment Style
Large Growth
Min. Initial Investment
2,500
Status
Open
TTM Yield
0.00%
Turnover
42%
Premium

Morningstar’s Analysis

Will PRHSX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Strong execution and skillful stock-picking earn this fund an upgrade.

Summary

| |

T. Rowe Price Health Sciences’ sound execution and skillful stock-picking results in a Morningstar Analyst Rating upgrade to Silver from Bronze.

Unlock our full analysis with Morningstar Premium